{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:53:21Z","timestamp":1785840801138,"version":"3.56.0"},"reference-count":53,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Nova Program of Science and Technology","award":["20240484706"],"award-info":[{"award-number":["20240484706"]}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7242239"],"award-info":[{"award-number":["7242239"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Development Fund Project of Beijing University of Chinese Medicine","award":["2024-ZXFZJJ-036"],"award-info":[{"award-number":["2024-ZXFZJJ-036"]}]},{"name":"Scientific Research Development Fund Project of Beijing University of Chinese Medicine","award":["2023-ZXFZJJ-017"],"award-info":[{"award-number":["2023-ZXFZJJ-017"]}]},{"award":["2024-ZXFZJJ-036"],"award-info":[{"award-number":["2024-ZXFZJJ-036"]}],"id":[{"id":"https:\/\/ror.org\/05damtm70","id-type":"ROR","asserted-by":"publisher"}]},{"award":["2023-ZXFZJJ-017"],"award-info":[{"award-number":["2023-ZXFZJJ-017"]}],"id":[{"id":"https:\/\/ror.org\/05damtm70","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the intestine. Although current therapies can provide symptomatic relief, they are often associated with high costs and adverse effects. Coptis chinensis Franch., a traditional Chinese medicine long used for inflammatory intestinal conditions such as bacterial dysentery, is a promising alternative. However, the specific alkaloid components that inhibit cell death and alleviate colitis remain unclear. Major isoquinoline alkaloids from Coptis chinensis Franch. were screened in a TNF-\u03b1\/cycloheximide (CHX)-induced epithelial cell death model using CCK-8 and Annexin V staining. Caspase-3 and GSDME cleavage, HMGB1 release, phosphorylation of ERK and JNK, and inflammatory gene expression were assessed by Western blotting and qPCR. In vivo, a Citrobacter rodentium-induced colitis model was established and mice were treated with a specific alkaloid. Disease severity, histopathological injury, bacterial burden, barrier-related structural markers, and colonic GSDME cleavage were then evaluated. Berberine (BBR) exhibited the strongest cytoprotective activity in the screening system, reducing epithelial cell death, reversing pyroptosis-associated morphology, and inhibiting GSDME cleavage. BBR also reduced HMGB1 release, attenuated the phosphorylation of ERK and JNK, and downregulated pro-inflammatory gene expression. In the C. rodentium-induced infectious colitis model, BBR alleviated body weight loss, diarrhea, colon shortening, and histopathological injury without significantly reducing bacterial burden under the present experimental conditions. In parallel, BBR enhanced Tjp1 and Muc2 expression, and diminished colonic GSDME cleavage in vivo. Collectively, these findings suggest that BBR is a promising candidate for colitis involving bacterial infection-associated epithelial pyroptosis, potentially via GSDME modulation.<\/jats:p>","DOI":"10.3390\/ijms27156820","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:01:46Z","timestamp":1785344506000},"page":"6820","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Berberine Alleviates Citrobacter rodentium-Induced Colitis with Reduced Epithelial Gasdermin E-Mediated Pyroptosis"],"prefix":"10.3390","volume":"27","author":[{"given":"Meiqi","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixian","family":"Wei","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Luo","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Li","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdong","family":"Kong","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Jia","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1419-3494","authenticated-orcid":false,"given":"Anlong","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China"},{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"},{"name":"Institute of Advanced Studies Hong Kong, Sun Yat-sen University, Hong Kong 999077, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-2920","authenticated-orcid":false,"given":"Xin","family":"Jia","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"jjaf040","DOI":"10.1093\/ecco-jcc\/jjaf040","article-title":"Novel outcomes in inflammatory bowel disease","volume":"19","author":"Jairath","year":"2025","journal-title":"J. Crohns Colitis"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrgastro.2017.110","article-title":"The IBD interactome: An integrated view of aetiology, pathogenesis and therapy","volume":"14","author":"Fiocchi","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cgh.2013.03.034","article-title":"Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation","volume":"12","author":"Kappelman","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/CM9.0000000000003542","article-title":"Epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years","volume":"138","author":"Wan","year":"2025","journal-title":"Chin. Med. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41575-020-0326-4","article-title":"Cell death in the gut epithelium and implications for chronic inflammation","volume":"17","author":"Patankar","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41575-022-00675-x","article-title":"The role of goblet cells and mucus in intestinal homeostasis","volume":"19","author":"Gustafsson","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1038\/s41467-025-58644-2","article-title":"Colonic epithelial-derived FGF1 drives intestinal stem cell commitment toward goblet cells to suppress inflammatory bowel disease","volume":"16","author":"Lin","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: Regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","article-title":"Pyroptosis: Molecular mechanisms and roles in disease","volume":"35","author":"Broz","year":"2025","journal-title":"Cell Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1016\/j.cell.2024.10.010","article-title":"Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair","volume":"187","author":"Jena","year":"2024","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/s41418-021-00755-6","article-title":"GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy","volume":"28","author":"Li","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1182\/blood.2023023179","article-title":"GSDME-mediated pyroptosis contributes to chemotherapy-induced platelet hyperactivity and thrombotic potential","volume":"144","author":"Xue","year":"2024","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13045-020-00985-0","article-title":"HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1\/2 pathway","volume":"13","author":"Tan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"goaf021","DOI":"10.1093\/gastro\/goaf021","article-title":"Gasdermin E-mediated intestinal epithelial pyroptosis promotes chemically induced colitis in mice","volume":"13","author":"Wu","year":"2025","journal-title":"Gastroenterol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100162","DOI":"10.1016\/j.jtauto.2022.100162","article-title":"Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis","volume":"5","author":"Xiao","year":"2022","journal-title":"J. Transl. Autoimmun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1186\/s12967-025-07012-1","article-title":"Nicotinamide riboside attenuates radiation-induced intestinal injury by suppressing gasdermin E-mediated pyroptosis in intestinal epithelial cells","volume":"23","author":"Zhou","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16658","DOI":"10.1021\/acsnano.4c01520","article-title":"Alleviating Pyroptosis of Intestinal Epithelial Cells to Restore Mucosal Integrity in Ulcerative Colitis by Targeting Delivery of 4-Octyl-Itaconate","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.gendis.2022.05.039","article-title":"Protective effects of IRG1\/itaconate on acute colitis through the inhibition of gasdermins-mediated pyroptosis and inflammation response","volume":"10","author":"Yang","year":"2023","journal-title":"Genes Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"153927","DOI":"10.1016\/j.phymed.2022.153927","article-title":"Effect of Coptis chinensis franch and Magnolia officinalis on intestinal flora and intestinal barrier in a TNBS-induced ulcerative colitis rats model","volume":"97","author":"Xie","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1142\/S0192415X23500945","article-title":"Coptis chinensis and Berberine Ameliorate Chronic Ulcerative Colitis: An Integrated Microbiome-Metabolomics Study","volume":"51","author":"Zhou","year":"2023","journal-title":"Am. J. Chin. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"154322","DOI":"10.1016\/j.phymed.2022.154322","article-title":"Coptis chinensis polysaccharides dynamically influence the paracellular absorption pathway in the small intestine by modulating the intestinal mucosal immunity microenvironment","volume":"104","author":"Yang","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"114444","DOI":"10.1016\/j.intimp.2025.114444","article-title":"Effects of three Chinese herbal therapies on gut microbiota and short-chain fatty acid metabolism in patients with mild, moderate, and severe ulcerative colitis: Multi-center, randomized, controlled trials","volume":"152","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"156179","DOI":"10.1016\/j.phymed.2024.156179","article-title":"Xianglian pill alleviates ulcerative colitis by inhibiting M1 macrophage polarization via modulation of energy metabolite itaconate","volume":"135","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"115690","DOI":"10.1016\/j.jep.2022.115690","article-title":"Xianglian Pill attenuates ulcerative colitis through TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"300","author":"Dai","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105694","DOI":"10.1016\/j.phrs.2021.105694","article-title":"Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner","volume":"170","author":"Li","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41419-020-2470-8","article-title":"Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105358","DOI":"10.1016\/j.phrs.2020.105358","article-title":"Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites","volume":"164","author":"Jing","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"154217","DOI":"10.1016\/j.phymed.2022.154217","article-title":"Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora","volume":"102","author":"Yan","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.7150\/ijbs.65476","article-title":"Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt\/\u03b2-catenin pathway","volume":"18","author":"Dong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13099-022-00514-z","article-title":"Jatrorrhizine alleviates ulcerative colitis via regulating gut microbiota and NOS2 expression","volume":"14","author":"Zhang","year":"2022","journal-title":"Gut Pathog."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"157054","DOI":"10.1016\/j.phymed.2025.157054","article-title":"Coptisine activates aryl hydrocarbon receptor to regulate colonic epithelial homeostasis in DSS induced ulcerative colitis and TNF-\u03b1 challenged intestinal organoids","volume":"145","author":"Tan","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"156831","DOI":"10.1016\/j.phymed.2025.156831","article-title":"Epiberberine ameliorates ulcerative colitis by regulating bile acids hepatoenteral circulation through intestinal FXR","volume":"143","author":"Chen","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"113396","DOI":"10.1016\/j.intimp.2024.113396","article-title":"Palmatine alleviates inflammation and modulates ferroptosis against dextran sulfate sodium (DSS)-induced ulcerative colitis","volume":"143","author":"Ji","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41419-018-1019-6","article-title":"HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer","volume":"9","author":"Huang","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3896147","DOI":"10.1155\/2016\/3896147","article-title":"High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications","volume":"2016","author":"Wu","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41579-019-0252-z","article-title":"Citrobacter rodentium-host-microbiota interactions: Immunity, bioenergetics and metabolism","volume":"17","author":"Hopkins","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"103751","DOI":"10.1016\/j.ebiom.2021.103751","article-title":"MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis","volume":"74","author":"Yao","year":"2021","journal-title":"eBioMedicine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"123862","DOI":"10.1016\/j.ijbiomac.2023.123862","article-title":"Orchestration of MUC2\u2014The key regulatory target of gut barrier and homeostasis: A review","volume":"236","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Miao, G., Zhang, D., Sui, Z., Leng, J., Deng, Y., Gu, X., and Cao, H. (2025). Berberine-taxifolin co-administration attenuates inflammatory response and intestinal barrier injury via nf-\u03baB\/NLRP3 suppression in colitis. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1725084"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.apsb.2019.08.006","article-title":"Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.2147\/DDDT.S436359","article-title":"Exploration of Berberine Against Ulcerative Colitis via TLR4\/NF-\u03baB\/HIF-1\u03b1 Pathway by Bioinformatics and Experimental Validation","volume":"18","author":"Li","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1158\/1940-6207.CAPR-19-0258","article-title":"A Phase I Trial of Berberine in Chinese with Ulcerative Colitis","volume":"13","author":"Xu","year":"2020","journal-title":"Cancer Prev. Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Li, J., Zhang, C., Xu, Y., and Yang, L. (2024). Efficacy and safety of berberine plus 5-ASA for ulcerative colitis: A systematic review and meta-analysis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0309144"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109265","DOI":"10.1016\/j.celrep.2021.109265","article-title":"Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn\u2019s disease by promoting intestinal inflammation","volume":"35","author":"Tan","year":"2021","journal-title":"Cell Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1016\/j.scib.2024.05.021","article-title":"Western diet induces GSDME-mediated epithelial pyroptosis through the DCA-S1PR2 pathway to disrupt the intestinal epithelial barrier","volume":"69","author":"Liu","year":"2024","journal-title":"Sci. Bull."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1038\/s41598-019-48331-w","article-title":"Berberine improved experimental chronic colitis by regulating interferon-\u03b3- and IL-17A-producing lamina propria CD4(+) T cells through AMPK activation","volume":"9","author":"Takahara","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"156111","DOI":"10.1016\/j.phymed.2024.156111","article-title":"Swiprosin-1 participates in the berberine-regulated AMPK\/MLCK pathway to attenuate colitis-induced tight junction damage","volume":"135","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ren, G., Ding, Y.W., Wang, L.L., and Jiang, J.D. (2023). Berberine stimulates lysosomal AMPK independent of PEN2 and maintains cellular AMPK activity through inhibiting the dephosphorylation regulator UHRF1. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1148611"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41422-023-00848-6","article-title":"Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P","volume":"33","author":"Ai","year":"2023","journal-title":"Cell Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1038\/s41401-023-01111-9","article-title":"Capsaicin functions as a selective degrader of STAT3 to enhance host resistance to viral infection","volume":"44","author":"Zhang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"121373","DOI":"10.1016\/j.jep.2026.121373","article-title":"Gynostemma pentaphyllum polysaccharides alleviate ulcerative colitis in mice via the Nrf2\/ROS\/NLRP3 axis and modulation of the gut microbiota","volume":"363","author":"Qiu","year":"2026","journal-title":"J. Ethnopharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6820\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:38:59Z","timestamp":1785839939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":53,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156820"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156820","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}